The store will not work correctly when cookies are disabled.
3-(5-hydroxy-1H-indol-3-yl)benzothioamide
ID: ALA4524641
PubChem CID: 132137210
Max Phase: Preclinical
Molecular Formula: C15H12N2OS
Molecular Weight: 268.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=S)c1cccc(-c2c[nH]c3ccc(O)cc23)c1
Standard InChI: InChI=1S/C15H12N2OS/c16-15(19)10-3-1-2-9(6-10)13-8-17-14-5-4-11(18)7-12(13)14/h1-8,17-18H,(H2,16,19)
Standard InChI Key: GQEYCSZFVPAZJV-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
15.3890 -3.8300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3879 -4.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0959 -5.0585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8056 -4.6491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8027 -3.8264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0941 -3.4212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5089 -3.4152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2182 -3.8211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0957 -5.8757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5058 -2.5980 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.4368 -6.3522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6892 -7.1295 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7590 -6.3525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5075 -7.1261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0512 -7.7286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8464 -7.5588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0951 -6.7811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5498 -6.1819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8936 -6.6072 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
3 9 1 0
7 10 2 0
9 11 2 0
11 12 1 0
12 14 1 0
13 9 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
17 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.34 | Molecular Weight (Monoisotopic): 268.0670 | AlogP: 3.17 | #Rotatable Bonds: 2 |
Polar Surface Area: 62.04 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.53 | CX Basic pKa: ┄ | CX LogP: 3.16 | CX LogD: 3.15 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.63 | Np Likeness Score: -0.09 |
References
1. (2017) Ash1l inhibitors and methods of treatment therewith, |